chr6-63721375-TTCTGCATG-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001142800.2(EYS):c.8648_8655delCATGCAGA(p.Thr2883LysfsTer4) variant causes a frameshift change. The variant allele was found at a frequency of 0.000365 in 1,551,816 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001142800.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.8648_8655delCATGCAGA | p.Thr2883LysfsTer4 | frameshift_variant | Exon 43 of 43 | ENST00000503581.6 | NP_001136272.1 | |
PHF3 | NM_001370348.2 | c.*7669_*7676delCTGCATGT | 3_prime_UTR_variant | Exon 16 of 16 | ENST00000262043.8 | NP_001357277.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.8648_8655delCATGCAGA | p.Thr2883LysfsTer4 | frameshift_variant | Exon 43 of 43 | 5 | NM_001142800.2 | ENSP00000424243.1 | ||
EYS | ENST00000370621.7 | c.8711_8718delCATGCAGA | p.Thr2904LysfsTer4 | frameshift_variant | Exon 44 of 44 | 1 | ENSP00000359655.3 | |||
PHF3 | ENST00000262043.8 | c.*7669_*7676delCTGCATGT | 3_prime_UTR_variant | Exon 16 of 16 | 5 | NM_001370348.2 | ENSP00000262043.4 | |||
PHF3 | ENST00000505138.1 | c.361+10015_361+10022delCTGCATGT | intron_variant | Intron 3 of 4 | 3 | ENSP00000421417.1 |
Frequencies
GnomAD3 genomes AF: 0.000644 AC: 98AN: 152126Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000750 AC: 118AN: 157422Hom.: 1 AF XY: 0.000698 AC XY: 58AN XY: 83080
GnomAD4 exome AF: 0.000335 AC: 469AN: 1399572Hom.: 1 AF XY: 0.000343 AC XY: 237AN XY: 690282
GnomAD4 genome AF: 0.000644 AC: 98AN: 152244Hom.: 1 Cov.: 32 AF XY: 0.000994 AC XY: 74AN XY: 74452
ClinVar
Submissions by phenotype
Retinitis pigmentosa 25 Pathogenic:8
- -
- -
- -
- -
The EYS c.8648_8655del variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2, PM3. Based on this evidence we have classified this variant as Pathogenic. -
NM_001142800.1:c.8648_8655delCATGCAGA in the EYS gene has an allele frequency of 0.006 in European (Finnish) subpopulation in the gnomAD database. This sequence change results in a premature translational stop signal in the EYS gene (p.Thr2883Lysfs*4). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 262 amino acids of the EYS protein. This variant has been observed in a patient with retinitis pigmentosa, in a compound heterozygous state with c.4350_4356del7 (p.K1450KfsX3) (PMID: 20537394). This variant is also known as c.8710_8717del8 (p.T2904KfsX4) in the literature. Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP Criteria applied: PVS1; PM3; PP4. -
- -
- -
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Thr2883Lysfs*4) in the EYS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 262 amino acid(s) of the EYS protein. This variant is present in population databases (rs528919874, gnomAD 0.6%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 20537394). It has also been observed to segregate with disease in related individuals. This variant is also known as c.8710_8717del8 (p.T2904KfsX4). ClinVar contains an entry for this variant (Variation ID: 550019). This variant disrupts a region of the EYS protein in which other variant(s) (p.Tyr2935*) have been determined to be pathogenic (PMID: 22363543). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Commonly seen in cis with the p.(C385*) variant in individuals of Finish background (Avela et al., 2018); Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 262 amino acids are lost and replaced with 3 incorrect amino acids; This variant is associated with the following publications: (PMID: 30718709, 20537394, 29159838, 28704921, 29550188, 31429209, 32531858, 29068140, 33833316) -
Retinal dystrophy Pathogenic:2
- -
- -
Retinitis pigmentosa Pathogenic:2
- -
Variant summary: EYS c.8648_8655delCATGCAGA (p.Thr2883LysfsX4) is located in the last exon, and results in a premature termination codon that is not expected to cause nonsense mediated decay (NMD), but is predicted to cause a truncation of the encoded protein, removing a part of the 3144 amino acids long protein. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 0.00075 in 157422 control chromosomes, predominantly at a frequency of 0.0064 within the Finnish subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency in the Finnish subpopulation is higher than the estimated maximal expected allele frequency for a pathogenic variant in EYS causing Retinitis Pigmentosa (0.0034). However, the Finnish subpopulation has been recently reported to be enriched for certain founder mutations in EYS (Avela_2018, Avela_2019). The presence of homozygotes in controls suggests that this variant may have incomplete penetrance and/or is associated with a later onset of disease. The variant, c.8648_8655delCATGCAGA, has been reported in the literature in multiple compound heterozygous and homozygous individuals affected with Retinitis Pigmentosa (e.g. Littink_2010, Westin_2021), and was also reported in cis with the c.1155T>A (p.Cys385X) variant in multiple Finish patients (Avela_2018, Avela_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Nine ClinVar submitters (evaluation after 2014) have cited the variant, and all laboratories classified the variant as pathogenic (n = 7) or likely pathogenic (n = 2). Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at